More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics


Show Summary Details

Quick Reference


an alkylating agent that destroys cancer cells by acting on the bone marrow. It is administered by mouth or intravenous infusion, mainly in the treatment of chronic myeloid leukaemia. Trade names:. Busilvex,. Myleran.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.